Clinical Efficacy of Bendamustine Plus Rituximab (BR) for B-cell Relevant Indolent Non-Hodgkin's Lymphoma and Role of <i>ß</i>2-MG in Predicting the Efficacy of BR Regimen: A Real-World Retrospective Study in China.

Zhang, Yujie; He, Donghua; He, Jingsong; Huang, Weijia; Yang, Yang; Cai, Zhen; Zhao, Yi

Clinical Efficacy of Bendamustine Plus Rituximab (BR) for B-cell Relevant Indolent Non-Hodgkin's Lymphoma and Role of ß2-MG in Predicting the Efficacy of BR Regimen: A Real-World Retrospective Study in China.

Zhang, Yujie; He, Donghua; He, Jingsong; Huang, Weijia; Yang, Yang; Cai, Zhen; Zhao, Yi.

Afiliação

Zhang Y; Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou City, Zhejiang Province, 310003, China.
He D; Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou City, Zhejiang Province, 310003, China.
He J; Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou City, Zhejiang Province, 310003, China.
Huang W; Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou City, Zhejiang Province, 310003, China.
Yang Y; Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou City, Zhejiang Province, 310003, China.
Cai Z; Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou City, Zhejiang Province, 310003, China.
Zhao Y; Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou City, Zhejiang Province, 310003, China.

Comput Math Methods Med ; 2022: 1080879, 2022.

Article em En | MEDLINE | ID: mdl-35096126

Assuntos

Protocolos de Quimioterapia Combinada Antineoplásica/administração & dosagem; Cloridrato de Bendamustina/administração & dosagem; Linfoma de Células B/sangue; Linfoma de Células B/tratamento farmacológico; Rituximab/administração & dosagem; Microglobulina beta-2/sangue; Idoso; Antineoplásicos Alquilantes/administração & dosagem; Antineoplásicos Imunológicos/administração & dosagem; Biomarcadores Tumorais/sangue; China; Biologia Computacional; Feminino; Humanos; Estimativa de Kaplan-Meier; Masculino; Pessoa de Meia-Idade; Prognóstico; Modelos de Riscos Proporcionais; Estudos Retrospectivos; Resultado do Tratamento

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células B / Microglobulina beta-2 / Cloridrato de Bendamustina / Rituximab Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Comput Math Methods Med Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google